CONMED Corp — Director's Dealing 2014

Aug 1, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-07-31

Reporting Person: Hartman Curt R (Interim CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-31	Common Stock	P	10000	$39.2496	Acquired	11000	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.23 to $39.25. Full information regarding the number of shares purchased at each separate price will be provided upon request of the commission staff, Conmed, or a Conmed security holder.